Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Seattle Genetics Company Profile (NASDAQ:SGEN)

Consensus Ratings for Seattle Genetics (NASDAQ:SGEN) (?)
Ratings Breakdown: 2 Sell Rating(s), 3 Hold Rating(s), 3 Buy Rating(s)
Consensus Rating:Hold (Score: 2.13)
Consensus Price Target: $45.30 (23.53% upside)

Analysts' Ratings History for Seattle Genetics (NASDAQ:SGEN)
Show:
DateFirmActionRatingPrice TargetDetailsShare
10/31/2014Cantor FitzgeraldUpgradeSell -> Hold$29.00 -> $35.00ViewTweet This Rating  Share This Rating on StockTwits
9/30/2014Bank of AmericaDowngradeNeutral -> Underperform$40.00 -> $34.00ViewTweet This Rating  Share This Rating on StockTwits
8/19/2014ZacksDowngradeOutperform -> Neutral$46.10ViewTweet This Rating  Share This Rating on StockTwits
5/6/2014Bank of AmericaUpgradeUnderperform -> Neutral$46.00 -> $40.00ViewTweet This Rating  Share This Rating on StockTwits
5/2/2014Cantor FitzgeraldBoost Price Target$24.00 -> $28.00ViewTweet This Rating  Share This Rating on StockTwits
5/2/2014Jefferies GroupReiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
4/28/2014Ned Davis ResearchUpgradeSell -> NeutralViewTweet This Rating  Share This Rating on StockTwits
3/10/2014Bank of AmericaInitiated CoverageBuy$65.00ViewTweet This Rating  Share This Rating on StockTwits
3/10/2014HC WainrightInitiated CoverageBuy$65.00ViewTweet This Rating  Share This Rating on StockTwits
2/24/2014Bank of AmericaInitiated CoverageUnderperform$46.00ViewTweet This Rating  Share This Rating on StockTwits
2/13/2014Credit SuisseBoost Price Target$46.00 -> $51.00ViewTweet This Rating  Share This Rating on StockTwits
2/13/2014GuggenheimBoost Price Target$33.00 -> $38.00ViewTweet This Rating  Share This Rating on StockTwits
2/12/2014Needham & Company LLCUpgradeHold -> BuyViewTweet This Rating  Share This Rating on StockTwits
12/20/2013RBC CapitalBoost Price Target$44.00 -> $48.00ViewTweet This Rating  Share This Rating on StockTwits
12/9/2013Piper JaffrayReiterated RatingUnderweightViewTweet This Rating  Share This Rating on StockTwits
9/18/2013Goldman SachsBoost Price Target$37.00 -> $42.00ViewTweet This Rating  Share This Rating on StockTwits
8/5/2013Leerink SwannBoost Price Target$42.00 -> $53.00ViewTweet This Rating  Share This Rating on StockTwits
8/2/2013Credit SuisseBoost Price Target$40.00 -> $46.00ViewTweet This Rating  Share This Rating on StockTwits
8/1/2013RBC CapitalBoost Price TargetOutperform$40.00 -> $44.00ViewTweet This Rating  Share This Rating on StockTwits
8/1/2013Jefferies GroupBoost Price TargetBuy$41.00 -> $45.00ViewTweet This Rating  Share This Rating on StockTwits
8/1/2013Cantor FitzgeraldBoost Price TargetSell$20.00 -> $24.00ViewTweet This Rating  Share This Rating on StockTwits
5/8/2013Leerink SwannBoost Price Target$36.00 -> $42.00ViewTweet This Rating  Share This Rating on StockTwits
5/8/2013Jefferies GroupBoost Price TargetBuy$35.00 -> $41.00ViewTweet This Rating  Share This Rating on StockTwits
5/7/2013Goldman SachsInitiated CoverageNeutral$37.00ViewTweet This Rating  Share This Rating on StockTwits
4/22/2013RBC CapitalBoost Price TargetOutperform$32.00 -> $40.00ViewTweet This Rating  Share This Rating on StockTwits
2/13/2013Leerink SwannBoost Price Target$27.00 -> $36.00ViewTweet This Rating  Share This Rating on StockTwits
2/13/2013Needham & Company LLCDowngradeBuy -> Hold$25.00ViewTweet This Rating  Share This Rating on StockTwits
12/6/2012Credit SuisseInitiated CoverageOutperformViewTweet This Rating  Share This Rating on StockTwits
11/12/2012Credit SuisseInitiated CoverageOutperform$28.00ViewTweet This Rating  Share This Rating on StockTwits
11/9/2012GuggenheimInitiated CoverageNeutralViewTweet This Rating  Share This Rating on StockTwits
11/8/2012Cantor FitzgeraldDowngradeHold -> Sell$30.00 -> $20.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 11/1/2012 forward)
Discuss Seattle Genetics